Glucagon

1. Overview

Glucagon is a peptide hormone crucial for glucose homeostasis. It serves as the physiological counter-regulatory hormone to insulin, increasing blood glucose levels by stimulating hepatic glucose production. Glucagon is secreted in response to hypoglycemia and plays a central role in maintaining normal glucose levels during fasting, stress, or prolonged physical activity. It is especially vital for protecting against dangerous drops in blood sugar.

2. Location

Glucagon is produced by the alpha (α) cells of the islets of Langerhans in the pancreas, primarily in the tail region. The pancreas is a retroperitoneal organ located behind the stomach. In addition to the pancreas, small amounts of glucagon may also be secreted by neuroendocrine cells in the gastrointestinal tract.

3. Structure

Glucagon is a 29-amino-acid peptide with a molecular weight of approximately 3.5 kDa. It is synthesized as a part of a larger precursor protein called preproglucagon, which is processed in pancreatic alpha cells to yield mature glucagon. In intestinal L-cells and some neurons, preproglucagon is processed differently to form GLP-1 and GLP-2 instead of glucagon. Glucagon is water-soluble and acts via membrane-bound G protein-coupled receptors.

4. Function

Glucagon’s primary function is to raise blood glucose levels, especially during fasting or hypoglycemia:

• Stimulates glycogenolysis: Breaks down liver glycogen stores into glucose.

• Enhances gluconeogenesis: Promotes synthesis of glucose from non-carbohydrate substrates such as amino acids and lactate.

• Inhibits glycolysis and lipogenesis in the liver to preserve glucose.

• Promotes lipolysis: Activates hormone-sensitive lipase in adipose tissue, increasing free fatty acid availability.

• Ketogenesis: Supports ketone body production in the liver during prolonged fasting.

5. Physiological role(s)

Glucagon plays a vital role in energy balance and nutrient mobilization:

• Fasting and starvation: Prevents hypoglycemia by ensuring a continuous supply of glucose via hepatic glycogenolysis and gluconeogenesis.

• Counter-regulatory to insulin: While insulin lowers blood glucose, glucagon raises it, maintaining homeostatic balance.

• Exercise: Increases during prolonged physical activity to support energy needs when glucose stores are depleted.

• Stress response: Glucagon is elevated in response to stress hormones (e.g., epinephrine, cortisol) and contributes to the metabolic shift during acute stress.

• Neuroendocrine integration: Works with catecholamines and cortisol to ensure metabolic support for the brain and other vital organs during emergencies.

6. Clinical Significance

Disorders related to glucagon can impact blood sugar control and overall metabolic health:

• Glucagonoma:

  • A rare pancreatic alpha-cell tumor that leads to excessive glucagon secretion.

  • Clinical features include hyperglycemia, weight loss, necrolytic migratory erythema (a characteristic skin rash), anemia, and diarrhea.

  • Treatment includes surgical resection, somatostatin analogs, and glucose control.

• Hypoglycemia treatment:

  • Glucagon is used as an emergency treatment for severe hypoglycemia, especially in unconscious diabetic patients unable to consume oral glucose.

  • Administered via intramuscular or intranasal formulations.

• Diabetes mellitus:

  • Type 1 diabetics may have inappropriately low glucagon responses during hypoglycemia, increasing their risk of severe episodes.

  • In Type 2 diabetes, glucagon levels may be elevated inappropriately after meals, contributing to postprandial hyperglycemia.

• Pharmacological research:

  • Glucagon receptor antagonists and dual GLP-1/glucagon receptor agonists are being studied for obesity and diabetes treatment.